Literature DB >> 22554506

Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability.

James C Brooks1, Weilin Sun, Gabriela Chiosis, Cynthia A Leifer.   

Abstract

Nucleic acid-sensing Toll-like receptors (TLRs) initiate innate immune responses to foreign RNA and DNA, yet can detect and respond to host DNA. To avoid autoimmune pathologies, nucleic acid sensing TLRs are tightly regulated. TLR9 primarily resides in the endoplasmic reticulum, traffics to endosomes, is proteolytically processed and responds to DNA. The heat shock protein gp96 is one of several accessory proteins that regulate intracellular trafficking of TLR9. In the absence of gp96, TLR9 fails to exit the endoplasmic reticulum, and therefore gp96-deficient macrophages fail to respond to CpG DNA. However, absence of gp96 precludes studies on potential chaperoning functions of gp96 for TLR9. Here we demonstrate that pharmacologic interference with gp96 function inhibits TLR9 signaling. TLR9 remains associated with gp96 during intracellular trafficking, and gp96-specific inhibitors increase TLR9 sensitivity to proteolytic degradation. We propose that gp96 is critical for both TLR9 egress from the ER, and for protein conformational stability in the endosomal compartment. These studies highlight the importance of examining gp96-specific inhibitors for modulating TLR9 activation, and the treatment autoimmune diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554506      PMCID: PMC3358552          DOI: 10.1016/j.bbrc.2012.04.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

Authors:  Sean R Christensen; Jonathan Shupe; Kevin Nickerson; Michael Kashgarian; Richard A Flavell; Mark J Shlomchik
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.

Authors:  Huazhong He; Danuta Zatorska; Joungnam Kim; Julia Aguirre; Laura Llauger; Yuhong She; Nian Wu; Robert M Immormino; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

Review 3.  Chaperoning steroid hormone action.

Authors:  Didier Picard
Journal:  Trends Endocrinol Metab       Date:  2006-06-27       Impact factor: 12.015

4.  Conformational lability of two molecular chaperones Hsc70 and gp96: effects of pH and temperature.

Authors:  Haihong Fan; Ramesh S Kashi; C Russell Middaugh
Journal:  Arch Biochem Biophys       Date:  2006-02-03       Impact factor: 4.013

5.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

Authors:  Koichi Tabeta; Kasper Hoebe; Edith M Janssen; Xin Du; Philippe Georgel; Karine Crozat; Suzanne Mudd; Navjiwan Mann; Sosathya Sovath; Jason Goode; Louis Shamel; Anat A Herskovits; Daniel A Portnoy; Michael Cooke; Lisa M Tarantino; Tim Wiltshire; Benjamin E Steinberg; Sergio Grinstein; Bruce Beutler
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

6.  Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.

Authors:  S M Roe; C Prodromou; R O'Brien; J E Ladbury; P W Piper; L H Pearl
Journal:  J Med Chem       Date:  1999-01-28       Impact factor: 7.446

7.  Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

Authors:  C E Stebbins; A A Russo; C Schneider; N Rosen; F U Hartl; N P Pavletich
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

8.  Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.

Authors:  Sean R Christensen; Michael Kashgarian; Lena Alexopoulou; Richard A Flavell; Shizuo Akira; Mark J Shlomchik
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

9.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

Review 10.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

View more
  16 in total

1.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

2.  Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Authors:  Hardik J Patel; Pallav D Patel; Stefan O Ochiana; Pengrong Yan; Weilin Sun; Maulik R Patel; Smit K Shah; Elisa Tramentozzi; James Brooks; Alexander Bolaender; Liza Shrestha; Ralph Stephani; Paola Finotti; Cynthia Leifer; Zihai Li; Daniel T Gewirth; Tony Taldone; Gabriela Chiosis
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

3.  SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.

Authors:  Hao Guo; Jialong Zhang; Xuyuan Zhang; Yanbing Wang; Haisheng Yu; Xiangyun Yin; Jingyun Li; Peishuang Du; Joel Plumas; Laurence Chaperot; Jianzhu Chen; Lishan Su; Yongjun Liu; Liguo Zhang
Journal:  J Immunol       Date:  2015-04-10       Impact factor: 5.422

Review 4.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 5.  The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Arch Biochem Biophys       Date:  2012-12-17       Impact factor: 4.013

6.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 7.  Molecular mechanisms of regulation of Toll-like receptor signaling.

Authors:  Cynthia A Leifer; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2016-06-24       Impact factor: 4.962

Review 8.  Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.

Authors:  Liza Shrestha; Hardik J Patel; Gabriela Chiosis
Journal:  Cell Chem Biol       Date:  2016-01-21       Impact factor: 8.116

9.  Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events.

Authors:  Siddhartha S Sinha; Jody Cameron; James C Brooks; Cynthia A Leifer
Journal:  J Immunol       Date:  2016-07-15       Impact factor: 5.422

Review 10.  Regulation of TLR7/9 signaling in plasmacytoid dendritic cells.

Authors:  Musheng Bao; Yong-Jun Liu
Journal:  Protein Cell       Date:  2012-11-07       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.